Healthcare provider profile · identity verified

Michael Bollaert, MD

Family Practice · MOLINE, IL · NPI 1487975066

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	668	160
Lisinopril	Lisinopril	491	131
Levothyroxine Sodium	Levothyroxine Sodium	413	94
Amlodipine Besylate	Amlodipine Besylate	407	105
Losartan Potassium	Losartan Potassium	346	88
Metformin Hcl	Metformin Hcl	281	80
Gabapentin	Gabapentin	276	65
Jardiance	Empagliflozin	225	45
Omeprazole	Omeprazole	211	50
Trazodone Hcl	Trazodone Hcl	210	52
Simvastatin	Simvastatin	201	59
Sertraline Hcl	Sertraline Hcl	199	51
Tamsulosin Hcl	Tamsulosin Hcl	193	45
Albuterol Sulfate Hfa	Albuterol Sulfate	176	58
Potassium Chloride	Potassium Chloride	168	44
Meloxicam	Meloxicam	159	51
Metoprolol Succinate	Metoprolol Succinate	150	35
Metoprolol Tartrate	Metoprolol Tartrate	144	24
Furosemide	Furosemide	143	44
Pantoprazole Sodium	Pantoprazole Sodium	133	43
Doxycycline Hyclate	Doxycycline Hyclate	119	93
Pravastatin Sodium	Pravastatin Sodium	109	28
Donepezil Hcl	Donepezil Hcl	108	suppressed
Clonazepam	Clonazepam	107	23
Prednisone	Prednisone	107	79
Alprazolam	Alprazolam	104	24
Glipizide Er	Glipizide	102	28
Hydrochlorothiazide	Hydrochlorothiazide	102	29
Rosuvastatin Calcium	Rosuvastatin Calcium	95	29
Zolpidem Tartrate	Zolpidem Tartrate	90	15
Lorazepam	Lorazepam	83	36
Montelukast Sodium	Montelukast Sodium	82	18
Azithromycin	Azithromycin	80	65
Glimepiride	Glimepiride	79	15
Bupropion Xl	Bupropion Hcl	76	25
Fluoxetine Hcl	Fluoxetine Hcl	76	13
Tramadol Hcl	Tramadol Hcl	74	22
Eliquis	Apixaban	73	14
Ozempic	Semaglutide	68	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	20
Famotidine	Famotidine	61	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	26
Glipizide	Glipizide	56	14
Rybelsus	Semaglutide	54	13
Nabumetone	Nabumetone	53	12
Paroxetine Hcl	Paroxetine Hcl	53	12
Pregabalin	Pregabalin	52	13
Venlafaxine Hcl Er	Venlafaxine Hcl	52	suppressed
Citalopram Hbr	Citalopram Hydrobromide	49	14
Escitalopram Oxalate	Escitalopram Oxalate	49	16
Breo Ellipta	Fluticasone/Vilanterol	48	suppressed
Atenolol	Atenolol	47	12
Triamcinolone Acetonide	Triamcinolone Acetonide	47	35
Fluticasone Propionate	Fluticasone Propionate	45	16
Trulicity	Dulaglutide	45	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	44	37
Metformin Hcl Er	Metformin Hcl	42	12
Topiramate	Topiramate	42	suppressed
Carvedilol	Carvedilol	40	suppressed
Lovastatin	Lovastatin	40	11
Ondansetron Odt	Ondansetron	40	20
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	suppressed
Alendronate Sodium	Alendronate Sodium	38	suppressed
Allopurinol	Allopurinol	38	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	11
Ezetimibe	Ezetimibe	37	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	25
Baclofen	Baclofen	36	suppressed
Farxiga	Dapagliflozin Propanediol	34	11
Levetiracetam	Levetiracetam	34	suppressed
Meclizine Hcl	Meclizine Hcl	33	15
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Naproxen	Naproxen	32	suppressed
Temazepam	Temazepam	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	12
Terazosin Hcl	Terazosin Hcl	25	suppressed
Diazepam	Diazepam	24	suppressed
Valsartan	Valsartan	24	suppressed
Fluconazole	Fluconazole	23	13
Tradjenta	Linagliptin	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Linzess	Linaclotide	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	11
Mounjaro	Tirzepatide	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Colchicine	Colchicine	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Primidone	Primidone	18	suppressed
Torsemide	Torsemide	18	suppressed
Alyacen	Norethindrone-Ethin. Estradiol	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Nystatin	Nystatin	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Atrovent Hfa	Ipratropium Bromide	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Amoxicillin	Amoxicillin	13	11
Creon	Lipase/Protease/Amylase	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Cephalexin	Cephalexin	12	12
Erythromycin	Erythromycin Base	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Phenytoin	Phenytoin	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error